ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1631 • 2017 ACR/ARHP Annual Meeting

    Hospital Readmissions for SLE in the United States: A National Database Study

    Narender Annapureddy1, Aparna Saha2 and Girish Nadkarni3, 1Vanderbilt University Medical Center, Nashville, TN, 2Department of Public Health, Icahn School of Medicine at Mount Sinai, New york, NY, 3Division of Nephrology, Icahn School of Medicine at Mount Sinai, New york, NY

    Hospital Readmissions For SLE In The United States: A National Database Study Background/Purpose: Systemic lupus erythematosus (SLE) is associated with significant mortality and morbidity, and…
  • Abstract Number: 1632 • 2017 ACR/ARHP Annual Meeting

    SLE Characteristics Associated with Modified Framingham Risk Score in Patients without Clinical Cardiovascular Disease

    Elizabeth George1, Thania Perez2, Nelson Perez3, Anca Askanase4 and Laura Geraldino-Pardilla5, 1Rheumatology, Columbia University College of Physicians and Surgeons, New york, NY, 2Columbia University College of Physicians & Surgeons, New York, NY, 3Hospital Regional Universitario Jose Maria Cabral y Baez, Santiago, Dominican Republic, 4Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 5Columbia University, New york, NY

     Background/Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in SLE and identifying those at risk remains challenging. While in the general population the…
  • Abstract Number: 1633 • 2017 ACR/ARHP Annual Meeting

    Use of Emergency Department (ED) and Resulting Hospitalization By Patients with Systemic Lupus Erythematosus (SLE) in a Predominantly Afro-Caribbean Inner-City Cohort

    Maushmi Savjani1, Justin Levinson2 and Ellen M. Ginzler3, 1Internal Medicine, Division of Rheumatology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 2Medicine, Division of Rheumatology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 3Rheumatology, Division of Rheumatology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY

    Background/Purpose: Given the complexity, chronicity and associated co-morbidities, management of SLE poses a challenge. Despite established care in private and fellow/resident clinics, our patients often…
  • Abstract Number: 1634 • 2017 ACR/ARHP Annual Meeting

    Body Mass Index and Disease Activity in Systemic Lupus Erythematosus- a Paradoxical Relationship?

    George Stojan1, Wei Fu2 and Michelle Petri3, 1Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD

    Background/Purpose: Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28 and…
  • Abstract Number: 1635 • 2017 ACR/ARHP Annual Meeting

    Cachexia in Systemic Lupus Erythematosus- an Underrecognized Syndrome

    George Stojan1, Laurence S Magder2,3 and Michelle Petri4, 1Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Epidemiology and Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, 3Epidemiology and Public health, University of Maryland School of Medicine, Baltimore, MD, 4Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD

    Background/Purpose: Cachexia is a syndrome that may accompany a range of diseases, including cancer, chronic heart failure, chronic obstructive pulmonary disease, and rheumatoid arthritis. It…
  • Abstract Number: 1636 • 2017 ACR/ARHP Annual Meeting

    Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus

    George Stojan1, Wei Fu2 and Michelle Petri3, 1Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Medicine (Rheumatology), Division of Rheumatology, Johns Hopkins University School of Medicine, MD, USA, Baltimore, MD

    Background/Purpose:   Obesity is more common in patients with SLE compared to the general population. The prevalence of obesity among SLE patients is between 28…
  • Abstract Number: 1637 • 2017 ACR/ARHP Annual Meeting

    Sexual Function in Married Indian Women with Systemic Lupus Erythematosus

    Benzeeta Pinto1, Sandeep Grover2, Manish Rathi3 and Aman Sharma4, 1PGIMER, CHANDIGARH, India, 2PGIMER, Chandigarh, India, 3Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 4Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Background/Purpose: This study was carried out to evaluate the impact of disease activity, damage, marital satisfaction, fatigue, psychiatric comorbidity and QoL on sexual function in…
  • Abstract Number: 1638 • 2017 ACR/ARHP Annual Meeting

    High Genetic Risk Score Is Associated with Increased Organ Damage in SLE

    Sarah Reid1, Andrei Alexsson1, Martina Frodlund2, Johanna K Sandling1, Elisabet Svenungsson3, Andreas Jönsen4, Christine Bengtsson5, Iva Gunnarsson3, Anders A. Bengtsson4, Solbritt Rantapaa-Dahlqvist5, Maija-Leena Eloranta1, Ann-Christine Syvänen6, Christopher Sjöwall2, Lars Rönnblom1 and Dag Leonard1, 1Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden, 2Department of Clinical and Experimental Medicine, Linköping University, Sweden, Linköping, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 4Lund University, Department of Clinical Sciences, Rheumatology, Lund, Sweden, 5Dept of Public Health and Clinical Medicine/Rheumatology, Umeå University, Sweden, Umeå, Sweden, 6Uppsala University, Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala, Sweden

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease with a complex genetic etiology. Over 80 risk genes for SLE have been identified and…
  • Abstract Number: 1639 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Evolution in a Nationwide Cohort Originally Classified As Mixed Connective Tissue Disease

    Silje Reiseter1, Ragnar Gunnarsson2, Jukka Corander3, Johanna Haydon4, May Brit Lund5 and Øyvind Molberg1, 1Oslo University Hospital, Oslo, Norway, 2Department of Rheumatology, Oslo University Hospital, Oslo, Norway, OSLO, Norway, 3Departement of Biostatistics, University of Oslo, Oslo, Norway, 4Rheumatology, Vestre Viken Hospital, Drammen, Norway, 5Respiratory Medicine, Oslo University Hospital, Oslo, Norway

    Background/Purpose: Ever since Mixed Connective Tissue Disease was presented as a distinct entity in 1972, it has been discussed whether MCTD represents an undifferentiated, transient…
  • Abstract Number: 1640 • 2017 ACR/ARHP Annual Meeting

    SLICC Damage Index Is Associated with Tubulointerstitial Nephritis on Lupus Nephritis Biopsies

    Cianna Leatherwood, Brigham and Women's Hospital, Boston, MA

    SLICC Damage Index is associated with Tubulointerstitial Nephritis on Lupus Nephritis BiopsiesKristin D’ Silva, Paul Hoover, Gearoid McMahon, Sushrut Waikar, Helmut Rennke, Karen Costenbader Background/Purpose:…
  • Abstract Number: 1641 • 2017 ACR/ARHP Annual Meeting

    Indications for Initial Renal Biopsy in Systemic Lupus Erythematosus: A Systematic Review of the Literature

    Andrew McKinnon1, Annaliese Tisseverasinghe2, Susan Barr3, Paul R. Fortin4, John G. Hanly5, Stephanie Keeling6 and Christine A. Peschken2, 1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, 2Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 3Medicine, University of Calgary, Calgary, AB, Canada, 4Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Québec, QC, Canada, 5Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, 6Department of Medicine, University of Alberta, Division of Rheumatology, Edmonton, AB, Canada

    Background/Purpose: Lupus nephritis (LN) is an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). An initial renal biopsy (RB) is…
  • Abstract Number: 1642 • 2017 ACR/ARHP Annual Meeting

    Role of Plaque in Predicting Cardiovascular Events in Women with Lupus over a 20 Year Followup

    Erika Joyce1, Linda Santelices2, Jennifer Mall2, Kristy Huysman2, Amy Xiaoqin Tang3, Michael Anderson2, Jennifer Elliott4, Amy H. Kao5,6 and Susan Manzi2, 1Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 2Medicine, Allegheny Health Network, Pittsburgh, PA, 3Lupus Center of Excellence, Allegheny Health Network Research Institute, Pittsburgh, PA, 4Allegheny Health Network, Pittsburgh, PA, 5EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 6EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA), Billerica, MA

    Background/Purpose: The increased risk of premature cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients has been well reported. Multiple series have demonstrated a higher…
  • Abstract Number: 1643 • 2017 ACR/ARHP Annual Meeting

    15 Year Comparative Analysis of Cardiovascular Events in Female Subjects with Lupus Versus Controls

    Erika Joyce1, Kristy Huysman2, Linda Santelices2, Michael Anderson2, Amy H. Kao3, Jennifer Elliott4, Jennifer Mall2, Amy Xiaoqin Tang5 and Susan Manzi2, 1Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 2Medicine, Allegheny Health Network, Pittsburgh, PA, 3EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 4Allegheny Health Network, Pittsburgh, PA, 5Lupus Center of Excellence, Allegheny Health Network Research Institute, Pittsburgh, PA

    Background/Purpose: The multi-organ sequelae of systemic lupus erythematosus (SLE) may include nephritis, alveolar hemorrhage, and cardiovascular disease. Our long term follow up of female SLE…
  • Abstract Number: 1644 • 2017 ACR/ARHP Annual Meeting

    Less Than Seven Hours of Sleep per Night Is Associated with Transitioning to Systemic Lupus Erythematosus

    Kendra A. Young1, Melissa E. Munroe2, Joel M. Guthridge3, Diane L. Kamen4, Gary S. Gilkeson5, Michael Weisman6, David Karp7, John B. Harley8, Daniel J. Wallace6, Judith A. James9 and Jill M. Norris10, 1Epidemiology, University of Colorado Denver, Aurora, CO, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, OKC, OK, 4Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, 5Department of Medicine, Medical University of South Carolina, Charleston, SC, 6Cedars-Sinai Medical Center Division of Rheumatology, Los Angeles, CA, 7Rheumatology, UT Southwestern Med Ctr, Dallas, TX, 8Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 10Department of Epidemiology, Colorado School of Public Health, Aurora, CO

    Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a relatively unknown etiology. The quality and quantity of sleep has been shown to…
  • Abstract Number: 1645 • 2017 ACR/ARHP Annual Meeting

    Tobacco Exposure and Relationship with Severe Damage in Systemic Lupus Erythematosus Patients

    Micaela Ana Cosatti1, Sebastian Muñoz2, Natalia Tamborenea3, Mercedes Argentina García4, Ana Curti5, Ana Maria Capuccio6, Oscar Rillo7, Patricia Imamura8,9,10, Emilce Schneeberger11, Fernando Dal Pra12, Marcela Ballent13, Mario Luis Cousseau14, Jorge Velasco Zamora15, Veronica Saurit16, Sergio M.A. Toloza17,18, Maria Danielsen19, Veronica Bellomio20, Cesar Graf21, Sergio Paira22, Javier Cavallasca23, Bernado Pons-Estel24, Jose Moreno25, Monica Patricia Diaz26, Paula Alba27, Marcela Verando28, Guillermo Tate3, Eduardo Mysler29, Judith Sarano30, Emma Civit31, Fabian Risueño32, Pablo Alvarez Sepúlveda33, Maria Silvia Larroude6, Marcos Mendez34, Andrea Conforti35, Debora Sohn36, Danith Medina Bornachera37, Samanta Malm- Green38, Analia Alvarez39, Claudia Andrea Helling40, Susana Roverano41, Gisela Pendón42, M. Mayer43, Josefina Marin44, Cecilia Catoggio45, Alicia Eimon46 and Cecilia N. Pisoni47, 1Section Rheumatology and Immunology, CEMIC, CABA, Argentina, 2Rheumatology Unit, Hospital “Dr. Juan A. Fernández”, CABA, Argentina, 3OMI, Buenos Aires, Argentina, 4Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 5rheumatology, Hospital de Clínicas José de San Martin, CABA, Argentina, 6Hospital Cesar Milstein, CABA, Argentina, 7Hospital Pirovano, CABA, Argentina, 8IMAI, Caba, Argentina, 9Rheumatology, Hosp Italiano de Buenos Aires, Buenos Aires, Argentina, 10Internal Medicine, Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 11Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 12Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, 13Hospital RamónSantamarina, Tandil, Argentina, 14Policlínica Privada Paz, Tandil, Argentina, 15Instituto Médico CER, Quilmes, Argentina, 16Rheumatology, Hospital Privado Córdoba, Cordoba, Argentina, 17Medicine, Hospital San Juan Bautista, Catamarca, Argentina, 18Hospital San Juan Bautista, Ciudad de San Fernando del Valle de Catamarca, Argentina, 19Rheumatology, Hospital Regional, Santiago del Estero, Argentina, 20Hospital Ángel Cruz Padilla, Tucuman, Argentina, 21Centro Médico Mitre, Paraná, Argentina, 22Reumatologia, Hospital J M Cullen, Santa Fe, Argentina, 23Hospital José Bernardo Iturraspe, San Francisco, Argentina, 24GLADEL, Rosario, Santa Fe, Argentina, 25Instituto Médico CER, San Juan, Argentina, 26Centro Traumatológico Bariloche, Bariloche, Argentina, 27Universidad Nacional de Cordoba, Rheumatology Unit Cordoba and Materno Neonatal Hospital, Córdoba, Argentina, 28Hospital General de Agudos Bernardino Rivadavia, CABA, Argentina, 29Organización Médica de Investigación, Buenos Aires, Argentina, 30Rheumatology Unit, Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, 31Hospital del Carmen, Godoy Cruz, Argentina, 32ITEMedica, Bahia Blanca, Argentina, 33Hospital Central de San Isidro, Buenos Aires, Argentina, 34Consultorios Pilar, Madryn, Argentina, 35OSEP Mendoza, Mendoza, Argentina, 3631Consultorio privado de reumatología, Buenos Aires, Argentina, 37Hospital Penna, CABA, Argentina, 38Hospital Bernardino Rivadavia, CABA, Argentina, 39Hospital Penna, Bahía Blanca, Argentina, 40URUGUAY 725, Omi, CABA, Argentina, 41Hospital José Maria Cullen, Santa Fe, Argentina, 42Hospital Ricardo Gutierrez, La Plata, Argentina, 43Hospital Británico, Buenos Aires, Argentina, 44Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 45Rheumatology and Immunology, Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina, 46CEMIC, Buenos Aires, Argentina, 47Internal Medicine, CEMIC, Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina

    Background/Purpose: to assess relationship between smoking exposure and organ damage accrual measured by Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic…
  • « Previous Page
  • 1
  • …
  • 1494
  • 1495
  • 1496
  • 1497
  • 1498
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology